FDA Import Refusal 799-9097640-9/11/1 — ASTRAZENECA PHARMA

ASTRAZENECA PHARMA — FEI 3013340698

The FDA refused shipment 799-9097640-9/11/1 from ASTRAZENECA PHARMA (India) on January 26, 2024. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 4 other import refusals on record.

Refusal Details

Date
January 26, 2024
Country
India
Product Category
Drugs and Biologics
Product Code
61PDB70 DAPAGLIFLOZIN (ANTI-DIABETIC)
Charges
75